Precision and diagnostic accuracy verification of VITROS HIV combo assay
DOI:
https://doi.org/10.15305/ijrci/v7i1/323Keywords:
HIV, precision, accuracy, sensitivity, specificityAbstract
Background/Objective: NACO has laid down three structured algorithms (I, II, III) for HIV screen, surveillance and diagnosis. It is the responsibility of the laboratories to select, verify and evaluate the methods fitting into the algorithm of HIV testing. The present study has attempted to evaluate VITROS® HIV combo assay through comparison with Abbott Architect HIV combo assay.
Method: The study evaluated VITROS® HIV combo assay through precision verification and diagnostic accuracy assessment by adopting CLSI guidelines. Precision verification of the VITROS HIV combo assay is done based on CLSI EP15A3 and diagnostic accuracy verification based on CLSI EP12A2.
Result: Precision verification showed a repeatability CV% (CVR) -2.35% and within lab CV% (CVWL)-3.77%. This was compared against the manufacturer’s claims (σR-3%, σWL-4.8%) and found to be within acceptable limits. Diagnostic accuracy verification showed that difference in paired sensitivity between VITROS® HIV combo assay and Abbott Architect HIV combo assay was zero and difference in paired specificities was 0.3%. This difference was proved to be statistically insignificant based on 95% confidence interval for the paired sensitivities and specificities.
Conclusion: The study showed an acceptable performance of VITROS HIV combo assay in terms of precision and diagnostic accuracy.
References
WHO | HIV/AIDS [Internet]. WHO. [cited 2020 Jan 3]. Available from: http://www.who.int/gho/hiv/en/
Davis DHJ, Smith R, Brown A, Rice B, Yin Z, Delpech V. Early diagnosis and treatment of HIV infection: magnitude of benefit on short-term mortality is greatest in older adults. Age Ageing. 2013 Jul;42(4):520–6.
Alexander TS. Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution. Clin Vaccine Immunol. 2016 Apr;23(4):249–53.
National_Guidelines_for_HIV_Testing_21Apr2016.pdf [Internet]. [cited 2020 Jan 3]. Available from: http://www.naco.gov.in/sites/default/files/National_Guidelines_for_HIV_Testing_21Apr2016.pdf
Carey and Clinical and Laboratory Standards Institute - 2014 - User verification of precision and estimation of b.pdf [Internet]. [cited 2020 Jan 3]. Available from: https://clsi.org/media/1431/ep15a3_sample.pdf
Clinical and Laboratory Standards Institute. User protocol for evaluation of qualitative test performance; approved guideline-2nd (ed) Wayne, PA, USA: CLSI; 2008. CLSI document EP12-A2.
HIV Combo Reagent Pack, Pub No. GEM1255_XUS-EN, version 3.0, page: 1-18
HIV Ag/Ab Combo, Pub No. 48-3504/R4, Page:1-8.
HIV DUO Ultra, Ref 3044309691 I – en – 2015/06, Biomerieux SA
Geenius HIV ½ Confirmatory Assay, 883601-2013/01, Page: 1-17.
Published
Issue
Section
License
Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the ‘Internet Journal of Rheumatology and Clinical Immunology’. All the published content, except where otherwise noted, is licensed under Creative Commons license (CC-BY).
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication of the manuscript in IJRCI, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
